In modern analytical technology, improving accuracy and speed has always been a key objective for the biotech and medical industries. A research team led by Distinguished Professor Cheng-Chung Chang at National Chung Hsing University has developed the Triple-F Platform (Molecular Fingerprint, Facial Recognition, and Fast Screening). This innovative platform integrates AI-driven molecular fingerprint recognition with spectroscopy technology, enabling label-free, rapid, and highly sensitive detection capabilities.
This technology operates similarly to facial recognition, using AI to establish a molecular fingerprint database that allows for precise identification of specific substances within test samples. The team has successfully published research on the application of the Triple-F Platform in detecting serum bilirubin in the journal Biosensors and Bioelectronics. More recently, they published a breakthrough study in Applied Physics Reviews on the platform’s use in COVID-19 antigen and antibody detection.
Revolutionizing Detection: How the Triple-F Platform Transforms Screening Methods
The Triple-F Platform is built upon three core technologies:
3D-RCW Nanoreagent – This specialized silver nanostructure forms a randomly interwoven nanowire framework, creating isotropic plasmon resonance and uniform hotspots. This enhances Raman signals by over 1,000 times, making molecular fingerprint identification significantly clearer.
Portable Raman Spectrometer with Fiber Optic Probe – Equipped with a fiber-optic CCD and probe, this device enables direct, non-destructive testing by being applied directly to the sample, eliminating the need for sample preparation or microfluidic chips.
AI Signal Processing Software – Using data optimization, dimensionality reduction, and machine learning techniques (such as CWMA, PCA, and SMOTE), the software converts detection data into a visual QR code, allowing for real-time cloud-based analysis.
Compared to conventional detection methods, the Triple-F Platform offers significant advantages: it requires no antibodies, enables rapid screening (under five minutes), can analyze mixed contaminants, is low-cost, and highly maintainable. These benefits make it a game-changing solution for biomedical, agricultural, and food safety applications. The platform not only dramatically enhances detection sensitivity but also allows for the rapid identification of low-concentration viral particles without the need for additional labeling reagents, demonstrating enormous potential in clinical and public health applications. Given the growing concerns over food safety, the Triple-F Platform has been further adapted for food testing. It has successfully identified multiple instances of Sudan Red dye contamination in commercially available food products, providing a powerful safeguard for food safety.
Expert Insights: Applications and Future Prospects
Distinguished Professor Cheng-Chung Chang stated that the successful development of the Triple-F Platform overcomes the limitations of weak Raman signals and challenges in quantification, allowing molecular fingerprint technology to be widely applied. He emphasized that in today’s world, where food safety concerns are prevalent, the platform can swiftly detect contaminants, providing real-time safety assurance for the food supply chain. Currently, the technology has been extended to agricultural applications (such as pesticide residue and crop virus detection) and biomedical diagnostics (including bilirubin, cancer cells, bacteria, antibodies, and antigens). Future plans include expanding its use in public health screening, such as epidemic monitoring and environmental contaminant detection.
As global demand for food safety solutions continues to rise, the Triple-F Platform is poised to become a benchmark for next-generation rapid screening technologies, paving the way for a new era in the global diagnostics industry.
Resource: AI幫建分子指紋資料庫 快速篩檢污染物維護食安
